Quantifying benefit-risk preferences for new medicines in rare disease patients and caregivers

BACKGROUND: Rare disease patients and caregivers face uncommon, serious, debilitating conditions often characterised by poor prognosis and limited treatment options. This study aimed to explore what they consider of value when choosing between hypothetical therapeutic options and to quantify both th...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, T., Aymé, S., Cassiman, D., Simoens, S., Morgan, M., Vandebroek, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881055/
https://www.ncbi.nlm.nih.gov/pubmed/27225337
http://dx.doi.org/10.1186/s13023-016-0444-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881055/
https://www.ncbi.nlm.nih.gov/pubmed/27225337
http://dx.doi.org/10.1186/s13023-016-0444-9

Ejemplares similares